Home › Agent Hub › Agent Tools › Part D coverage by drug › Ramelteon
Agent Tools
Ramelteon is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,050 of 5,492 Medicare Part D and Medicare Advantage drug plans (73.7%) list Ramelteon on their formulary, across 205 of 286 formularies. The most common placement is tier 4 (2,104 plans, 52% of those covering it). 0 of the covering plans require prior authorization (0%), 1 step therapy and 3,981 a quantity limit.
515 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $10, 162 of them $0; 3,535 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 3,972 of 5,496 plans covered it (72.3%); 2027: 4,050 of 5,492 (73.7%).
Of 4,367 plans offered in both years, 30 added it to the formulary and 53 dropped it.
Among plans covering it both years, 58 moved it to a higher tier and 69 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 111 |
| Tier 2 | 325 |
| Tier 3 | 1,510 |
| Tier 4 | 2,104 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 111 of 323 | 34.4% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,396 of 3,200 | 74.9% | 0% |
| Special needs plans (SNP) | 1,543 of 1,969 | 78.4% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 4 | 0 |
| UnitedHealthcare | 757 of 830 | Tier 4 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 186 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 4 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 4 | 0 |
| Zing Health | 36 of 36 | Tier 2 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 4 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 27 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 96 of 114 | 84.2% |
| Alaska | 3 of 9 | 33.3% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 119 of 147 | 81% |
| Arkansas | 61 of 85 | 71.8% |
| California | 259 of 397 | 65.2% |
| Colorado | 78 of 106 | 73.6% |
| Connecticut | 34 of 54 | 63% |
| Delaware | 27 of 43 | 62.8% |
| District of Columbia | 7 of 12 | 58.3% |
| Florida | 402 of 545 | 73.8% |
| Georgia | 102 of 149 | 68.5% |
| Guam | 0 of 1 | 0% |
| Hawaii | 39 of 50 | 78% |
| Idaho | 32 of 45 | 71.1% |
| Illinois | 98 of 132 | 74.2% |
| Indiana | 114 of 138 | 82.6% |
| Iowa | 45 of 64 | 70.3% |
| Kansas | 51 of 84 | 60.7% |
| Kentucky | 96 of 121 | 79.3% |
| Louisiana | 98 of 125 | 78.4% |
| Maine | 38 of 52 | 73.1% |
| Maryland | 33 of 49 | 67.3% |
| Massachusetts | 76 of 89 | 85.4% |
| Michigan | 114 of 182 | 62.6% |
| Minnesota | 49 of 63 | 77.8% |
| Mississippi | 73 of 104 | 70.2% |
| Missouri | 117 of 170 | 68.8% |
| Montana | 20 of 27 | 74.1% |
| Nebraska | 33 of 51 | 64.7% |
| Nevada | 60 of 100 | 60% |
| New Hampshire | 20 of 25 | 80% |
| New Jersey | 47 of 73 | 64.4% |
| New Mexico | 61 of 68 | 89.7% |
| New York | 148 of 215 | 68.8% |
| North Carolina | 140 of 176 | 79.5% |
| North Dakota | 18 of 26 | 69.2% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 129 of 171 | 75.4% |
| Oklahoma | 62 of 81 | 76.5% |
| Oregon | 61 of 92 | 66.3% |
| Pennsylvania | 237 of 323 | 73.4% |
| Puerto Rico | 61 of 64 | 95.3% |
| Rhode Island | 21 of 29 | 72.4% |
| South Carolina | 64 of 89 | 71.9% |
| South Dakota | 18 of 30 | 60% |
| Tennessee | 139 of 156 | 89.1% |
| Texas | 304 of 407 | 74.7% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 42 of 53 | 79.2% |
| Vermont | 9 of 14 | 64.3% |
| Virginia | 118 of 144 | 81.9% |
| Washington | 83 of 114 | 72.8% |
| West Virginia | 50 of 69 | 72.5% |
| Wisconsin | 81 of 96 | 84.4% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 281,850 30-day fills of Ramelteon in 2024 for about 65,554 enrollees, at an average total cost of $81.34 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Ramelteon and the rest of a client's list on every plan in their county.
Estimate Ramelteon costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.